T. Rowe Price Associates
ATXS icon

T. Rowe Price Associates’s Astria Therapeutics ATXS Stock Holding History

T. Rowe Price Associates’s Portfolio ATXS Stock Details ATXS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$143K Sell
2025
Q2 		$116K Buy
2025
Q1 		$108K Buy
2024
Q4 		$159K Buy
2024
Q3 		$164K Hold
2024
Q2 		$136K Buy
2024
Q1 		$200K Buy
2021
Q4 		– Sell
2021
Q3 		$106K Sell
2021
Q2 		$151K Sell
2021
Q1 		$212K Buy